Holcim spin-off Amrize targets robust growth in US construction market

The building materials company said on Tuesday it aims for annual growth in adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) of about 8-11% between 2025 and 2028, alongside annual sales growth of 5-8%.
An Amrize listing by the end of the first half of 2025 remains on track, the company said in a statement. Holcim targeted a
"The company will invest in organic and inorganic growth, with a capital allocation strategy to drive growth and outperformance," said Holcim, whose chairman
The Amrize separation is likely to be one of the biggest deals in the global construction industry, which is grappling with the impact of tariffs on key building materials such as steel and aluminium imposed by U.S. President Donald Trump.
Amrize, which has over 1,000 sites across
Jenisch said during a presentation to investors in
The company said it was positioned to grow stronger than the market in its building envelope operations, and
In 2024, Amrize generated
The U.S. construction market is dealing with high interest rates weighing on residential and commercial construction, while inflation is reducing the impact of government projects.
"The U.S. construction market going into 2025 continues to face headwinds, namely the adverse effects of high interest rates on private construction," said PCA economist
"On the commercial side, high interest rates coupled with uncertainty regarding tariffs and potential softening in the economy have hampered activity."
Holcim shareholders must approve the spin-off at their AGM on
(Reporting by
(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Related News
-
Update: Portage Biotech Shares Jump Premarket After 'Promising' Preclinical Results in Mesothelioma
MT Newswires - 14 minutes ago
-
DraftKings Insider Sold Shares Worth $25,071,608, According to a Recent SEC Filing
MT Newswires - 14 minutes ago
-
EverCommerce Insider Sold Shares Worth $271,456, According to a Recent SEC Filing
MT Newswires - 17 minutes ago
-
Penumbra Insider Sold Shares Worth $3,405,253, According to a Recent SEC Filing
MT Newswires - 17 minutes ago
-
Italian police arrest 'Breaking Bad' fan in meth lab bust
Reuters - 17 minutes ago
-
Benzinga - 17 minutes ago
-
F&G Annuities & Life Insider Bought Shares Worth $359,618, According to a Recent SEC Filing
MT Newswires - 20 minutes ago
-
Akero Therapeutics Insider Bought Shares Worth $8,787,921, According to a Recent SEC Filing
MT Newswires - 21 minutes ago